FDA Warns Siemens On Marketing Claims For Syngo Arterial Health Package

FDA's recent warning letter to Siemens Medical is an example of the agency's recent crackdown on unapproved marketing and promotional claims by device manufacturers

More from Archive

More from Medtech Insight